Parkinson's Disease Tulip


advertisement
Reply
 
Thread Tools Display Modes
Old 01-09-2017, 08:16 PM #1
eds195 eds195 is offline
Member
 
Join Date: Feb 2015
Location: NJ
Posts: 153
8 yr Member
eds195 eds195 is offline
Member
 
Join Date: Feb 2015
Location: NJ
Posts: 153
8 yr Member
Default New Parkinson's Drug May Combat Movement Difficulties

Opicapone, added to standard treatment, appears safe and well-tolerated, researchers say

New Parkinson's Drug May Combat Movement Difficulties: MedlinePlus Health News
eds195 is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
lab rat (01-10-2017)

advertisement
Reply

Tags
appears, researchers, safe, treatment, well-tolerated

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off


Similar Threads
Thread Thread Starter Forum Replies Last Post
New Parkinson's Drug May Aid Movement Difficulties - WebMD NewsBot Parkinson's News 0 01-04-2017 11:00 PM
Experimental Parkinson's drug may combat movement difficulties - UPI.com NewsBot Parkinson's News 0 01-04-2017 10:51 AM
New Parkinson's Drug May Combat Movement Difficulties - Health.com NewsBot Parkinson's News 0 01-03-2017 10:40 PM
Join. Parkinson's Movement pegleg Parkinson's Disease 1 02-18-2014 11:39 AM
Parkinson's Movement jeanb Parkinson's Disease 10 08-16-2011 10:06 AM


All times are GMT -5. The time now is 07:25 AM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.